Global
589M
Adults aged 20–79 estimated to be living with diabetes worldwide in 2024.
International Diabetes Federation
Diabetes, Foot Care & Footwear
Evidence-based foot health research
Diabetes, Foot Care & Footwear
A foot problem does not always begin with a dramatic injury. For people living with diabetes, reduced sensation, circulation problems, foot deformities and repeated mechanical pressure can quietly turn a small problem into a serious one.
This research hub explains what happens, how common diabetic foot complications are, what current clinical guidance says about footwear, and where the evidence has genuine limitations.
Global diabetes burden
589M
adults aged 20–79 living with diabetes
The International Diabetes Federation estimates that 589 million adults were living with diabetes globally in 2024. Its projection reaches 853 million by 2050.
IDF Diabetes Atlas, 11th Edition
6.3% Estimated global prevalence of diabetic foot ulcers reported in a major systematic review.
19–34% Estimated lifetime risk of diabetic foot ulceration reported in major evidence reviews.
31.4% Estimated adult diabetes prevalence in Pakistan in the IDF's 2024 country estimate.
Research at a glance
The numbers tell only part of the story.
These figures are useful for understanding scale, but prevalence, lifetime risk and projections are different measurements. A responsible research page should never mix them together.
Foot ulcer
6.3%
Estimated global prevalence of diabetic foot ulcers in adults with diabetes.
Systematic review / meta-analysis
Lifetime
19–34%
Estimated lifetime risk of developing a diabetic foot ulcer.
Diabetes Care evidence review
Pakistan
34.5M
Estimated adults living with diabetes in Pakistan in 2024.
International Diabetes Federation
The danger is not simply that a person with diabetes may develop a foot wound. The deeper problem is that they may not feel the injury early enough.
Why protective sensation matters in diabetic foot careThe central issue
Why a "small" foot problem can become a serious one
Diabetes can affect the nerves and blood vessels that support the feet. When protective sensation is reduced, normal pain signals may become less reliable.
That changes the meaning of everyday pressure. A shoe that repeatedly rubs one area, a blister caused by friction, or a small object inside footwear may continue causing damage because the person does not receive the normal warning signal.
This is why diabetic foot prevention is not simply about buying a softer shoe. It involves risk assessment, daily observation, appropriate footwear, pressure management and timely professional care.
How diabetes affects the foot
Four mechanisms researchers watch closely
Diabetic foot complications usually arise through interacting risk factors rather than one isolated cause.
Peripheral neuropathy
Nerve damage can reduce protective sensation, making pressure, heat, friction and injury harder to detect.
Circulation problems
Peripheral artery disease can reduce blood flow and may make wound healing more difficult.
Foot deformity
Structural changes can alter how forces are distributed across the foot during walking.
Repeated pressure
Repeated mechanical loading and friction can contribute to callus formation and tissue damage.
The risk pathway
Foot ulcers rarely appear out of nowhere.
A diabetic foot ulcer can emerge from a chain of interacting events. Neuropathy may reduce awareness of injury; abnormal pressure may repeatedly load the same area; deformity can concentrate that pressure; and circulation problems can complicate healing.
Research insight
The American Diabetes Association identifies peripheral neuropathy, peripheral artery disease, foot deformity, pre-ulcerative calluses and a history of ulceration or amputation among important risk factors.
At-risk
foot Multiple factors
foot Multiple factors
Reduced sensation
Poor circulation
Foot deformity
Repeated pressure
Global scale
Diabetes is not a small or local problem.
The latest IDF estimates show the number of adults living with diabetes continuing to rise.
Adults aged 20–79 living with diabetes
Millions of adults - 2024 estimate versus 2050 projection
589M
2024
853M
2050
2024: 589 million adults. 2050: 853 million projected. The second figure is a projection, not an observed population count.
Pakistan research snapshot
Pakistan deserves its own section.
Pakistan has a substantial diabetes burden, and published studies report a significant burden of diabetic foot ulceration. However, estimates vary considerably between studies, so a responsible page must show the source and methodology instead of presenting one number as an absolute national rate.
34.53M Estimated adults with diabetes in Pakistan, 2024.
31.4% Estimated adult diabetes prevalence, 2024.
18% Pooled DFU prevalence in a newer Pakistan meta-analysis.
Why the Pakistan 18% figure needs context
A 2025 meta-analysis reported an 18% pooled prevalence from 16 studies involving 15,333 participants. The researchers also reported substantial regional and study-level variation. It should therefore be presented as a pooled research estimate, not as the exact prevalence for every person with diabetes in Pakistan.
Pakistan data
Put the statistics in context.
These values come from different sources and answer different questions. They should not be combined into a single "risk score."
Diabetes prevalence
Adults in Pakistan, IDF 2024 estimate
IDF country estimate for 2024.
Diabetic foot ulcer research
Pooled estimate from a 2025 meta-analysis
16 studies; 15,333 participants. Study heterogeneity and methodology remain important.
Understanding diabetic foot ulcers
Prevalence is not the same as lifetime risk.
This distinction is easy to miss and extremely important on a research page.
A prevalence estimate describes how many people in a defined population have a condition at a particular point or period.
A lifetime-risk estimate asks a different question: how likely a person with diabetes may be to develop a foot ulcer over their lifetime.
Therefore, figures such as 6.3% and 19–34% should never be presented as though they are two measurements of exactly the same thing.
Good health research does not hide uncertainty. It explains where the number came from.
A principle for interpreting diabetic foot statisticsFrom risk to complication
The diabetic-foot pathway, simplified.
The actual clinical picture is more complicated, but this model shows why prevention focuses on sensation, pressure, fit and early detection.
Diabetes → reduced sensation → unnoticed pressure or trauma → tissue damage → ulcer → possible infection and delayed healing.
Simplified educational model - not a diagnostic pathway.Footwear and pressure
What can footwear actually do?
Footwear can protect the foot and influence mechanical loading. But the evidence does not justify turning every soft or cushioned shoe into a "diabetic shoe."
Protect from external trauma
Appropriate footwear creates a physical barrier between the foot and environmental hazards.
Fit matters
Inadequate length or width can create pressure and increase mechanical stress on vulnerable areas.
Pressure redistribution
Therapeutic footwear and orthotic devices can be designed to reduce excessive plantar loading.
Cushioning is not the whole story
A soft sole may feel comfortable while the footwear still creates pressure elsewhere or fits poorly.
High-risk feet are different
Neuropathy, deformity, previous ulcers and poor circulation may require specialist footwear assessment.
Consistent use matters
Having appropriate footwear is less useful if it is not actually worn when protection is needed.
Supported
Pressure reduction
Clinical guidance and footwear research support the use of appropriately designed therapeutic footwear and orthoses to reduce excessive plantar pressure in selected high-risk feet.
Needs caution
"Soft shoe = ulcer prevention"
That conclusion is too broad. The ADA notes that much footwear research measures plantar-pressure reduction rather than directly demonstrating prevention of ulcers.
Practical evidence
What should be considered when evaluating footwear?
| Feature | Why it matters | What the evidence supports |
|---|---|---|
| Length | Prevents excessive pressure at the toes. | Adequate length is an important component of appropriate footwear fit. |
| Width | Helps avoid excessive side pressure. | Poor fit can increase mechanical stress. |
| Depth | Allows space for toes and deformities. | Particularly relevant to higher-risk feet. |
| Pressure redistribution | Reduces excessive loading at vulnerable areas. | Supported for appropriately designed therapeutic footwear and orthoses. |
| Cushioning | May influence comfort and impact. | Cushioning alone does not establish therapeutic or ulcer-prevention status. |
| Custom footwear | Can accommodate significant deformity and individual pressure patterns. | May be appropriate for selected high-risk patients. |
Daily prevention
Foot care is a habit, not a one-time purchase.
Appropriate footwear matters, but it sits inside a much larger prevention strategy.
✓
Inspect your feet every day
Look for cuts, blisters, redness, swelling, cracks, calluses and other changes.
✓
Check between the toes
Pay attention to skin damage and excessive moisture.
✓
Avoid barefoot walking when at risk
Especially important for people with reduced protective sensation or previous ulceration.
✓
Check footwear before wearing
Look for objects, rough edges, damaged areas or anything that could rub the foot.
✓
Protect dry skin
Moisturizer may be used for dry skin, while avoiding application between the toes.
✓
Attend regular foot examinations
The ADA recommends comprehensive foot evaluation at least annually for people with diabetes.
ADA 2026 guidance
The American Diabetes Association recommends a comprehensive foot evaluation at least annually. People with sensory loss or a history of ulceration or amputation require more frequent attention.
When footwear is no longer the main question
A person with diabetes should not try to solve an active foot problem simply by changing footwear. Professional medical assessment may be necessary.
Open wound or ulcer
Increasing redness
New swelling
Increased warmth
Pus or drainage
Sudden foot-color change
Persistent blister or skin damage
Fever or infection symptoms
NeoStep
Everyday footwear comfort and practical foot-protection information.
Why NeoStep is publishing this page
Research should inform the product conversation - not be used to replace it.
NeoStep can discuss footwear characteristics such as fit, cushioning, sole construction, everyday comfort and protection. But those characteristics should not be turned into unsupported medical promises.
A consumer slipper is not automatically therapeutic footwear simply because it is soft, cushioned or comfortable.
People with neuropathy, previous ulcers, significant deformities, poor circulation or other high-risk characteristics may need footwear assessed by an appropriate healthcare professional.
Medical information on this page is educational and does not replace diagnosis, treatment or individualized advice from a qualified healthcare professional.
Reader questions
What people usually want to know
Footwear needs depend on individual risk. People without high-risk foot characteristics may use appropriately fitting everyday footwear. People with loss of protective sensation, deformity, previous ulceration, poor circulation or other high-risk features may require specialized therapeutic footwear.
Not automatically. Cushioning can be one component of footwear design, but softness alone does not establish that footwear is therapeutic or prevents diabetic foot ulcers. Fit, pressure distribution, protection and the individual's clinical risk all matter.
Peripheral neuropathy can reduce protective sensation. That can make it harder for a person to notice pressure, friction, heat or an injury before significant tissue damage develops.
The ADA's 2026 Standards recommend a comprehensive foot evaluation at least annually for people with diabetes. People with sensory loss or previous ulceration or amputation require more frequent inspection and risk-based care.
No. Footwear is one part of prevention. Diabetes management, foot screening, daily inspection, pressure management and timely treatment remain important.
How to read the research on this page
The statistics presented here come from different research designs. They are intentionally labeled rather than combined into a single score.
Prevalence describes the proportion of a defined population with a condition.
Lifetime risk estimates the probability of experiencing a condition over a lifetime.
Projection estimates a future population under specified assumptions.
Sources & further reading
Follow the evidence to the original source.
For journalists, researchers and health writers, primary guidelines and peer-reviewed evidence should take priority over commercial summaries.
American Diabetes Association - Standards of Care 2026
Current clinical recommendations for neuropathy, foot screening, risk assessment and therapeutic footwear.
International Working Group on the Diabetic Foot
International guidance on prevention, footwear, pressure management and diabetic foot risk.
International Diabetes Federation
Global and country-level diabetes estimates, including Pakistan.
World Health Organization
Background information on diabetes and its complications.
Pakistan Diabetic Foot Ulcer Meta-analysis
Recent pooled evidence examining diabetic foot ulcer prevalence in Pakistan.
PubMed
Biomedical literature database for finding peer-reviewed diabetic foot research.
The goal of good diabetic foot care is not to find one magical shoe. It is to reduce preventable injury, recognize problems early and match footwear and care to the person's actual level of risk.
NeoStep Foot Health Research Resource
